2005
DOI: 10.1111/j.1365-2826.2005.01380.x
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Oestrogenic Compounds on Monoamine Transporters in Rat Striatum

Abstract: Oestrogens have been reported to modulate rat membrane (DAT) and vesicular (VMAT(2)) dopamine transporters. A recent pilot study of postmenopausal women showed that chronic oestrogen replacement therapy increases striatal DAT. In the present study, we first investigated whether the oestrogen receptors alpha and beta mediate the effects of oestradiol on DAT and VMAT(2). Two days after ovariectomy, Sprague-Dawley rats were treated for 2 weeks with oestradiol or specific ligands for oestrogen receptor alpha, 4,4'… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
58
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 72 publications
(61 citation statements)
references
References 42 publications
3
58
0
Order By: Relevance
“…OVX had been proposed to model gonadal hormone withdrawal occurring at menopause (Bosse and Di Paolo, 1995;Le Saux and Di Paolo, 2006;Vaillancourt et al, 2002). In support of this notion, we showed previously that OVX disrupts LI and impairs the efficacy of APDs to restore LI in OVX rats, in line with reduced APD efficacy reported in menopausal women with schizophrenia .…”
Section: Discussionsupporting
confidence: 69%
“…OVX had been proposed to model gonadal hormone withdrawal occurring at menopause (Bosse and Di Paolo, 1995;Le Saux and Di Paolo, 2006;Vaillancourt et al, 2002). In support of this notion, we showed previously that OVX disrupts LI and impairs the efficacy of APDs to restore LI in OVX rats, in line with reduced APD efficacy reported in menopausal women with schizophrenia .…”
Section: Discussionsupporting
confidence: 69%
“…For example, subcutaneous administration of DPN produced antianxiety behavior, which is believed to be mediated in the brain (34). In addition, subcutaneous administration of DPN produced an increase in striatal dopamine transporter binding that was similar to that observed following subcutaneous administration of EB (21). Finally, subcutaneous administration of PPT increased progesterone receptor mRNA expression in the arcuate nucleus and ventromedial hypothalamus (18).…”
mentioning
confidence: 68%
“…The dopamine transporter, DAT, is a protein that mediates the active reuptake of dopamine from the synapse and is a principal regulator of dopaminergic neurotransmission, dopamine receptor 1 and 2 (D 1 and D 2 , respectively) are modulated by 17β-estradiol and testosterone. Experiments using ovariectomized adult rats have shown a significant reduction of DAT levels in the NAcc and Striatum, which is restored to normal levels after E 2 replacement or the use of diarylpropionitrile (a selective ERβ agonist) and tamoxifen (selective estrogen receptor modulator) [45][46][47][48]. In the same model, levels of D 1 in mPOA are decreased after E 2 replacement [49].…”
Section: Sex Hormones Dopaminergic Neurotransmission and Addictionmentioning
confidence: 73%